Inhaled Molgramostim (rhGM-CSF) in Healthy Adult Subjects

Clinical trial NCT02468908 · COMPLETED

Trial details

NCT number: NCT02468908
Sponsor: Savara Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pulmonary Alveolar Proteinosis Bronchiectasis Cystic Fibrosis Acute Respiratory Distress Syndrome

Start date: 2015-05-01
Primary completion: 2015-10-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.